Zymeworks (ZYME) Exchange Rate Effect (2021 - 2026)
Zymeworks (ZYME) reported Exchange Rate Effect of $98000.0 for Q1 2026, up 880.0% on a YoY basis from $10000.0 in Q1 2025, and up 322.73% sequentially from -$44000.0 in Q4 2025.
Zymeworks (ZYME) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Zymeworks (ZYME) has 6 years of Exchange Rate Effect data on file, last reported at $98000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect rose 880.0% year-over-year to $98000.0; the trailing twelve-month figure through Mar 2026 stood at $43000.0 (down 75.71% YoY), and the FY2025 full-year result was -$45000.0, down 115.73% from the prior year.
- Exchange Rate Effect grew to $98000.0 in Q1 2026, from -$44000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $346000.0 in Q1 2023 to a low of -$123000.0 in Q1 2022.
- A 5-year average of $52705.9 and a median of $23000.0 in 2023 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect jumped 3866.67% in 2024 and slumped 241.94% in 2025, its largest moves.
- Tracing ZYME's Exchange Rate Effect over 5 years: stood at -$88000.0 in 2022, then surged by 96.59% to -$3000.0 in 2023, then jumped by 3866.67% to $113000.0 in 2024, then plunged by 138.94% to -$44000.0 in 2025, then surged by 322.73% to $98000.0 in 2026.
- Business Quant data shows ZYME's Exchange Rate Effect at $98000.0 in Q1 2026, -$44000.0 in Q4 2025, and $77000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | 98,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98,000.00 |
| Mar 31, 2026 | 98,000.00 |
| Dec 31, 2025 | -44,000.00 |
| Dec 31, 2025 | -44,000.00 |
| Sep 30, 2025 | 77,000.00 |
| Sep 30, 2025 | 77,000.00 |
| Jun 30, 2025 | -88,000.00 |
| Jun 30, 2025 | -88,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 113,000.00 |
| Dec 31, 2024 | 113,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | 62,000.00 |
| Jun 30, 2024 | 62,000.00 |
| Mar 31, 2024 | 119,000.00 |
| Mar 31, 2024 | 119,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Dec 31, 2023 | -3,000.00 |